Chongkundang (001630.KS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7001630003
Price
35,300.00 KRW
Market cap
168.05 bn KRW
P/E (2025)
–
P/S (2025)
0.18
Dividend yield
3.97 %
Net margin
4.22 %
Return on equity (ROE)
4.43 %
Return on assets (ROA)
2.48 %
Chongkundang financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 957.75 bn KRW | 959.01 bn KRW |
| Gross profit | 444.58 bn KRW | 427.30 bn KRW |
| Operating income | 35.49 bn KRW | 58.28 bn KRW |
| EBIT | 60.98 bn KRW | 85.81 bn KRW |
| Net income | 33.60 bn KRW | 40.43 bn KRW |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Chongkundang
Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. Chong Kun Dang Holdings Corp. was founded in 1941 and is based in Seoul, South Korea.
More stocks
- Cardiol Therapeutics Inc Class A (CRDL.TO)
- RheinLand Holding AG (RLV.DU)
- GalaxiaMoneytree Co.Ltd (094480.KQ)
- Greenland Resources Inc (MOLY.NE)
- Bokusgruppen AB (BOKUS.ST)
- PPX Mining Corp (PPX.V)
- LEWAG Holding (KGR.F)
- Mercuries Data Systems Ltd (2427.TW)
- Young Poong Precision Corporation (036560.KQ)
- Atlas Salt Inc (SALT.V)
- Baby Bunting Group Ltd (BBN.AX)
- Arlen SA (ARL.WA)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.